GLP-1 · Peptide Guide
Tirzepatide tracker
Also known as: Mounjaro, Zepbound
Log Tirzepatide (Mounjaro, Zepbound) doses and progress in AI Peps.
What is Tirzepatide?
Tirzepatide activates both GIP and GLP-1 receptors, producing greater weight loss than Semaglutide in head-to-head trials. Titration starts at 2.5 mg weekly and increases every 4 weeks up to 15 mg. AI Peps tracks each weekly injection, titration steps, weight trends, and side-effect notes.
Common doses
2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg (titration)
Frequency
Once weekly
Cycle length
Ongoing with 4-week titration steps
Administration
Subcutaneous injection (abdomen, thigh, or upper arm)
Storage
Refrigerate pens at 2–8°C; in use, per label instructions
Why track Tirzepatide in AI Peps
- ✦Highest average weight loss of current GLP-1 class
- ✦Dual GIP + GLP-1 mechanism
- ✦Improved A1C and insulin sensitivity
- ✦Once-weekly dosing
Considerations
- ·Prescription medication — use under medical supervision
- ·GI side effects common; slow titration helps
- ·Rotate injection sites
AI Peps is a tracking tool, not medical advice. Always consult a qualified clinician before starting any peptide or GLP-1 protocol.
Tirzepatide — frequently asked questions
Does AI Peps support Mounjaro and Zepbound tracking?
Yes. AI Peps has Tirzepatide templates matching Mounjaro and Zepbound titration schedules (2.5 mg → 15 mg in 2.5 mg steps) with weekly reminders.
Can I log side effects during Tirzepatide titration?
Yes. Each logged dose supports free-form notes so you can capture nausea, appetite changes, or energy — AI Peps surfaces patterns over your cycle.
Track Tirzepatide the smart way
Download AI Peps free on the App Store — dose logging, cycle tracking, and AI insights for Tirzepatide.
Related peptide guides
Healing
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It is widely researched for its role in tissue repair, tendon and ligament healing, and gut integrity.
Healing
TB-500
TB-500 is a synthetic fragment of Thymosin Beta-4 studied for systemic healing, cell migration, and recovery from soft-tissue injury.
GLP-1
Semaglutide
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy).